The Magdalen Centre
Oxford Science Park
Oxford
OX4 4GA
+44 (0)1865 784980
+44 (0)8701 671931
Roger Jones
Physiomics plc combines systems biology with cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the company's lead service, is used to optimise the dosing and scheduling of oncology drgus in pre-clinical trials. This optimisation improves the efficacy of combinations in pre-clinical xenografts.
| Description | Report Date | Published |
|---|---|---|
| Annual Report 2012 | 30-06-2012 | 14-11-2012 |
| Annual Report 2011 | 30-06-2011 | 11-10-2011 |
| Annual Report 2010 | 30-06-2010 | 15-11-2010 |
| Annual Report 2009 | 30-06-2009 | 30-11-2009 |
| Annual Report 2008 | 30-06-2008 | 26-11-2008 |
| Annual Report 2007 | 30-06-2007 | 19-11-2007 |
| Annual Report 2006 | 30-06-2006 | 30-11-2006 |
| Description | Report Date | Published |
|---|---|---|
| Interim Report 2012 | 31-12-2012 | 01-01-1970 |
| Interim Report 2011 | 31-12-2011 | 01-01-1970 |
| Interim Report 2010 | 31-12-2010 | 09-03-2011 |
| Interim Report 2009 | 31-12-2009 | 01-03-2010 |
| Interim Report 2008 | 31-12-2008 | 10-02-2009 |
| Interim Report 2007 | 31-12-2007 | 28-03-2008 |
| Interim Report 2006 | 31-12-2006 | 16-03-2007 |
| Interim Report 2005 | 31-12-2005 | 31-03-2006 |
| Description |
|---|
| Investor Relations |
| Home |
| Results Index |
| Press Releases |
| Contacts |
| Type | Dividend | Payment Date |
|---|